Cargando…

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease

A wide spectrum of comorbidities has been associated with Parkinson’s disease (PD), a progressive neurodegenerative disease that affects more than seven million people worldwide. Emerging evidence indicates that chronic diseases including diabetes, depression, anemia and cancer may be implicated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago, Jose A., Bottero, Virginie, Potashkin, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722846/ https://www.ncbi.nlm.nih.gov/pubmed/29255414 http://dx.doi.org/10.3389/fnagi.2017.00394

Ejemplares similares

Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
por: Santiago, Jose A., et al.
Publicado: (2018)

Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology
por: Santiago, Jose A., et al.
Publicado: (2017)

Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
por: Santiago, Jose A., et al.
Publicado: (2019)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
por: Bottero, Virginie, et al.
Publicado: (2022)

Transcriptomic and Network Meta-Analysis of Frontotemporal Dementias
por: Bottero, Virginie, et al.
Publicado: (2021)

Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson’ Disease
por: Santiago, Jose A., et al.
Publicado: (2017)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

Transcriptomic and Network Analysis Identifies Shared and Unique Pathways across Dementia Spectrum Disorders
por: Santiago, Jose A., et al.
Publicado: (2020)

Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
por: Bottero, Virginie, et al.
Publicado: (2019)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

A Comparison of Gene Expression Changes in the Blood of Individuals Consuming Diets Supplemented with Olives, Nuts or Long-Chain Omega-3 Fatty Acids
por: Bottero, Virginie, et al.
Publicado: (2020)

Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene
por: Potashkin, Judith A., et al.
Publicado: (2020)

Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients
por: Potashkin, Judith A., et al.
Publicado: (2019)

Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
por: Santiago, Jose A., et al.
Publicado: (2023)

Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2014)

Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
por: Santiago, Jose A., et al.
Publicado: (2013)

Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
por: Bottero, Virginie, et al.
Publicado: (2021)

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
por: Santiago, Jose A., et al.
Publicado: (2015)

Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
por: Santiago, Jose A., et al.
Publicado: (2016)

Sex-specific transcriptional rewiring in the brain of Alzheimer’s disease patients
por: Santiago, Jose A., et al.
Publicado: (2022)

Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
por: Santiago, Jose A., et al.
Publicado: (2014)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome
por: Nashiry, Md Asif, et al.
Publicado: (2023)

Implications of DNA Methylation in Parkinson’s Disease
por: Miranda-Morales, Ernesto, et al.
Publicado: (2017)

Stereopsis and Eye Movement Abnormalities in Parkinson’s Disease and Their Clinical Implications
por: Ba, Fang, et al.
Publicado: (2022)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases
por: Santiago, Jose A., et al.
Publicado: (2023)

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
por: Gao, Fei, et al.
Publicado: (2017)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
por: Lhommée, Eugénie, et al.
Publicado: (2014)

Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson’s Disease: Implications for Clinical Practice
por: Yang, Liu, et al.
Publicado: (2017)

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease
por: Miguelez, Cristina, et al.
Publicado: (2014)

Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients
por: Santiago, Jose A., et al.
Publicado: (2021)

Physical Activity Rewires the Human Brain against Neurodegeneration
por: Santiago, Jose A., et al.
Publicado: (2022)

Cerebellar Influence on Motor Cortex Plasticity: Behavioral Implications for Parkinson’s Disease
por: Kishore, Asha, et al.
Publicado: (2014)

Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson’s Disease
por: Leandrou, Emmanouela, et al.
Publicado: (2019)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Editorial: Parkinson's disease: cell vulnerability and disease progression
por: Blesa, Javier, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2qt7p1sksuce950g7k57chivmm